In conclusion, suppression of p16 in tumor cells decreases the expression of interleukins, chemokines and other factors belonging to the SASP that in turn may remodel the tumor microenvironment, thereby impairing immunological surveillance (Figure 1). Here, CDKN2A is linked to neoplasm.